ESG (Environmental, Social and Governance) Survey on Pharmaceutical Manufacturing – Towards a Sustainable Supply Chain
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Sustainability referred to as environmental, social, and governance (ESG), is gaining prominence and is likely to continue doing so in the coming years. Social inequality, corruption, tax avoidance, and a lack of action on climate change are all issues that companies must now address head-on, in full public view.
This ESG survey on pharmaceutical manufacturing report examines the pharmaceutical supply chain through the lens of ESG: In what ways does pharmaceutical manufacturing impact the society? How sustainable are its current practices? With what goals and methods can the industry improve its sustainability?
GlobalData ESG Framework
For more insights on ESG framework, download a free report sample
ESG Survey on Pharmaceutical Manufacturing - Poll Questions
GlobalData ran six polls on its Verdict network of B2B websites:
Q1: What is the most important sustainability area that the pharma industry needs to address?
Q2: Do you think that the pharma industry is doing enough to be more environmentally sustainable?
Q3: What is the main challenge to pharmaceutical companies achieving sustainable manufacturing?
Q4: How can the pharmaceutical industry best reduce its damage to the environment (end-of-pipe actions)?
Q5: How can the pharmaceutical industry best reduce its damage to the environment (pre-/post-manufacturing actions)?
Q6: What factors can motivate the pharma industry to improve its environmental, social, and governance actions?
ESG on Pharmaceutical Manufacturing – Key Findings
In the GlobalData survey, environmental sustainability is the top priority for respondents. Thus, pharma manufacturing must be made more environmentally sustainable. The supply chains might also be made more secure through onshoring, manufacturer diversification, and stockpiling.
To know more about key survey findings on ESG in pharmaceutical manufacturing, download a free report sample
ESG on Pharmaceutical Manufacturing – Challenges and solutions
The key challenges to pharmaceutical manufacturing are lack of investment in expertise/technology, lack of buy-in from management/key stakeholders, not identifying environmental impacts of products early enough in their lifecycle, and others. According to the GlobalData pharmaceutical manufacturing, ESG survey lack of investment in expertise/technology is the main challenge.
The pharmaceutical industry can best reduce its damage to the environment (end-of-pipe actions) by reducing carbon emissions and overall energy consumption.
To know more about challenges and solutions in ESG in pharmaceutical manufacturing, download a free report sample
Market Overview
Key Challenges | Lack of Investment in Expertise/Technology, Lack of Buy-In From Management/Key Stakeholders, Not Identifying Environmental Impacts of Products Early Enough in their Lifecycle, and Others |
Key Solutions | Reducing Carbon Emissions and Overall Energy Consumption |
Key Sustainability Area | Environment |
Scope
This page report gives important, expert insight you won’t find in any other source. 23 figures and graphics throughout the report illustrate major points and trends. This report is required reading for:
- CMO executives and strategic decision-makers: improve understanding of the pharma manufacturing industry and is a critical input for strategic ESG planning efforts.
- Sourcing and procurement executives in bio/pharmaceutical companies: improving understanding of crucial components of the supply base that will provide insights for supplier selection and management.
- Investors: they can gain a deeper understanding of the pharma manufacturing industry and the forces driving change.
Reasons to Buy
ESG should not be an exercise in corporate “greenwashing”, and this report is a realistic look at the pharma industry’s actions and values. We assess the industry’s will to change, and pragmatic motivations that can influence company behavior.
Table of Contents
Frequently asked questions
-
What are the main challenges faced by pharmaceutical companies to achieve sustainable manufacturing?
The key challenges faced by pharmaceutical manufacturing companies are lack of investment in expertise/technology, lack of buy-in from management/key stakeholders, and not identifying environmental impacts of products early enough in their lifecycle among others.
-
What is the key challenge to pharmaceutical companies achieving sustainable manufacturing?
Lack of investment in expertise/technology is the key challenge faced by pharmaceutical companies to achieve sustainable manufacturing.
-
What is the key solution for environmental concerns for pharmaceutical companies achieving sustainable manufacturing?
The pharmaceutical industry can best reduce its damage to the environment (end-of-pipe actions) by reducing carbon emissions and overall energy consumption.
-
What is the most important sustainability area that the pharma industry needs to address?
The environment is the most important sustainability area that the pharma industry needs to address.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.